| Product Code: ETC10708750 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Opioid Induced Constipation Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Opioid Induced Constipation Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Opioid Induced Constipation Market - Industry Life Cycle |
3.4 Canada Opioid Induced Constipation Market - Porter's Five Forces |
3.5 Canada Opioid Induced Constipation Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Canada Opioid Induced Constipation Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Canada Opioid Induced Constipation Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Canada Opioid Induced Constipation Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Opioid Induced Constipation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions requiring opioid therapy |
4.2.2 Growing awareness and diagnosis of opioid-induced constipation |
4.2.3 Rising adoption of novel pharmacological treatments for opioid-induced constipation |
4.3 Market Restraints |
4.3.1 Stringent regulatory landscape surrounding opioid prescriptions |
4.3.2 Concerns regarding the abuse potential and side effects of opioid medications |
5 Canada Opioid Induced Constipation Market Trends |
6 Canada Opioid Induced Constipation Market, By Types |
6.1 Canada Opioid Induced Constipation Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Canada Opioid Induced Constipation Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Canada Opioid Induced Constipation Market Revenues & Volume, By Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs), 2021 - 2031F |
6.1.4 Canada Opioid Induced Constipation Market Revenues & Volume, By Laxatives, 2021 - 2031F |
6.1.5 Canada Opioid Induced Constipation Market Revenues & Volume, By Prokinetic Agents, 2021 - 2031F |
6.1.6 Canada Opioid Induced Constipation Market Revenues & Volume, By Natural Remedies, 2021 - 2031F |
6.2 Canada Opioid Induced Constipation Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Canada Opioid Induced Constipation Market Revenues & Volume, By Receptor Blockade, 2021 - 2031F |
6.2.3 Canada Opioid Induced Constipation Market Revenues & Volume, By Osmotic, 2021 - 2031F |
6.2.4 Canada Opioid Induced Constipation Market Revenues & Volume, By Gut Motility Enhancement, 2021 - 2031F |
6.2.5 Canada Opioid Induced Constipation Market Revenues & Volume, By Fiber Supplements, 2021 - 2031F |
6.3 Canada Opioid Induced Constipation Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Canada Opioid Induced Constipation Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.3.3 Canada Opioid Induced Constipation Market Revenues & Volume, By Oral Solutions, 2021 - 2031F |
6.3.4 Canada Opioid Induced Constipation Market Revenues & Volume, By Injections, 2021 - 2031F |
6.3.5 Canada Opioid Induced Constipation Market Revenues & Volume, By Powders, 2021 - 2031F |
6.4 Canada Opioid Induced Constipation Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Canada Opioid Induced Constipation Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Canada Opioid Induced Constipation Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Canada Opioid Induced Constipation Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Canada Opioid Induced Constipation Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 Canada Opioid Induced Constipation Market Import-Export Trade Statistics |
7.1 Canada Opioid Induced Constipation Market Export to Major Countries |
7.2 Canada Opioid Induced Constipation Market Imports from Major Countries |
8 Canada Opioid Induced Constipation Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed opioid-induced constipation treatments |
8.2 Number of healthcare providers trained in managing opioid-induced constipation |
8.3 Frequency of educational campaigns and initiatives on opioid-induced constipation |
8.4 Percentage of opioid users experiencing constipation despite treatment |
9 Canada Opioid Induced Constipation Market - Opportunity Assessment |
9.1 Canada Opioid Induced Constipation Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Canada Opioid Induced Constipation Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Canada Opioid Induced Constipation Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Canada Opioid Induced Constipation Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Opioid Induced Constipation Market - Competitive Landscape |
10.1 Canada Opioid Induced Constipation Market Revenue Share, By Companies, 2024 |
10.2 Canada Opioid Induced Constipation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here